Companion Medical Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 4
Employees
  • Latest Deal Type
  • M&A
  • (Announced)
  • Investors
  • 5

Companion Medical General Information

Description

Developer of an insulin delivery system designed to improve diabetes care. The company's insulin delivery system combines Bluetooth technology and an easy-to-use smartphone application which provides constant tracking, monitoring and calculations necessary for insulin therapy, enabling diabetes patients to keep track of injection data.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Application Software
Primary Office
  • 12230 World Trade Drive
  • Suite 100
  • San Diego, CA 92128
  • United States
+1 (844) 000-0000

Companion Medical Timeline

2017201820192020
Financing RoundFinancing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Companion Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 11-Aug-2020 000.00 Announced Generating Revenue
6. Debt - PPP 09-Apr-2020 000.00 Completed
5. Debt - General 10-Jan-2020 000.00 000.00 Completed Generating Revenue
4. Early Stage VC 03-May-2018 000.00 0000 000.00 Completed Generating Revenue
3. Early Stage VC (Series B) 21-May-2015 00.00 00.00 00.00 Completed Generating Revenue
2. Grant 01-Sep-2014 $5K $403K Completed Generating Revenue
1. Early Stage VC (Series A) 14-May-2014 $403K $403K 00.00 Completed Generating Revenue
To view Companion Medical’s complete valuation and funding history, request access »

Companion Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A 3,266,658 $0.000100 8% $0.15 $0.15 1x $0.15 8.87%
To view Companion Medical’s complete cap table history, request access »

Companion Medical Executive Team (6)

Name Title Board Seat Contact Info
Sean Saint Chief Executive Officer & Board Member
Michael Mensinger Co-Founder, Chief Technology Officer & Board Member
Jasper Benke Vice President of RA, Quality Assurance and CA
Jennifer Halsey Strategic Advisor
You’re viewing 4 of 6 executive team members. Get the full list »

Companion Medical Board Members (5)

Name Representing Role Since
Aaron Berez MD Companion Medical Board Member 000 0000
Anders Essen-Moller Diamyd Medical Board Member 000 0000
Divakar Ramakrishnan Ph.D Eli Lilly Board Member 000 0000
Michael Mensinger Companion Medical Co-Founder, Chief Technology Officer & Board Member 000 0000
Sean Saint Companion Medical Chief Executive Officer & Board Member 000 0000
To view Companion Medical’s complete board members history, request access »

Companion Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Companion Medical Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Fox Ventures Corporate Venture Capital Minority 000 0000 000000 0
Eli Lilly Corporation Minority 000 0000 000000 0
Tech Coast Angels Angel Group 000 0000 000000 0
Diamyd Medical Corporation Minority 000 0000 000000 0
San Diego Venture Group Venture Capital Minority 000 0000 000000 0
To view Companion Medical’s complete investors history, request access »